Even though we employed constant infusion of CPG-1668 over the course of the experiment, this method probably had a more dramatic TLR9 stimulatory effect in immune cells rather than in tumor cells, which was probably important for augmenting the host-mediated antitumor immunity that resulted in tumor suppression. The gene discussed is TLR9; the disease is neoplasm.